Detection of circulating tumor cell subpopulations in patients with head and neck squamous cell carcinoma (HNSCC)

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Weller, Patrick ^a   Nel, Ivonne ^b   Hassenkamp, Philipp ^a,b   Gauler, Thomas ^b   Schlueter, Anke ^a   Lang, Stephan ^a   Dountsop, Paulette ^c   Hoffmann, Andreas Claudius ^b   Lehnerdt, Götz ^a,d  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c Children s Hospital   (Germany)

^d St Anna Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; CD133 ANTIGEN; CD45 ANTIGEN; CYTOKERATIN; NERVE CELL ADHESION MOLECULE; LEUKOCYTE ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CANCER SURVIVAL; CELL COUNT; CELL NUCLEUS; CELL SUBPOPULATION; CELL TYPE; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; ENRICHMENT CULTURE; EPITHELIUM CELL; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEAD AND NECK SURGERY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; KAPLAN MEIER METHOD; MALE; MESENCHYMAL STEM CELL; MESENCHYME CELL; PILOT STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; SURVIVAL TIME; BLOOD; CARCINOMA, SQUAMOUS CELL; CELL LINEAGE; EPITHELIAL MESENCHYMAL TRANSITION; GENETICS; HEAD AND NECK NEOPLASMS; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR EMBOLISM;

AGED; ANTIGENS, CD; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CELL LINEAGE; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING;

EID: 84917739345     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113706     Document Type: Article

References (31)

1. Lianidou ES, Markou A (2011) Circulating tumor cells as emerging tumor biomarkers in breast cancer. Clin Chem Lab Med 49: 1579-1590.
2. O'Flaherty JD, Gray S, Richard D, Fennell D, O'Leary JJ, et al. (2012) Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer. Lung Cancer 76: 19-25.
3. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, et al. (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10: 6897-6904.
4. Hou JM, Krebs M, Ward T, Sloane R, Priest L, et al. (2011) Circulating tumor cells as a window on metastasis biology in lung cancer. Am J Pathol 178: 989-996.
5. Moldenhauer G, Momburg F, Moller P, Schwartz R, Hammerling GJ (1987) Epithelium-specific surface glycoprotein of Mr 34, 000 is a widely distributed human carcinoma marker. Br J Cancer 56: 714- 721.
6. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, et al. (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351: 781-791.
7. Gauler TC, Theegarten D, Parr A, Schuhr I, Schmid KW, et al. (2011) Decrease of Circulating Tumor Cells Associates with Response to Platinum-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer, but Not with Small Cell Lung Cancer. Journal of Thoracic Oncology 6: S1114-S1114.
8. Nguyen PT, Kudo Y, Yoshida M, Kamata N, Ogawa I, et al. (2011) N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition. Histol Histopathol 26: 147-156.
9. Jatana KR, Balasubramanian P, Lang JC, Yang LY, Jatana CA, et al. (2010) Significance of Circulating Tumor Cells in Patients With Squamous Cell Carcinoma of the Head and Neck. Archives of Otolaryngology-Head & Neck Surgery 136: 1274-1279.
10. Balasubramanian P, Lang JC, Jatana KR, Miller B, Ozer E, et al. (2012) Multiparameter Analysis, including EMT Markers, on Negatively Enriched Blood Samples from Patients with Squamous Cell Carcinoma of the Head and Neck. PLoS One 7.
11. Winter SC, Stephenson SA, Subramaniam SK, Paleri V, Ha K, et al. (2009) Long term survival following the detection of circulating tumour cells in head and neck squamous cell carcinoma. BMC Cancer 9.
12. Hristozova T, Konschak R, Stromberger C, Fusi A, Liu Z, et al. (2011) The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN). Annals of Oncology 22: 1878-1885.
13. Nichols AC, Lowes LE, Szeto CC, Basmaji J, Dhaliwal S, et al. (2012) Detection of circulating tumor cells in advanced head and neck cancer using the CellSearch system. Head Neck 34: 1440-1444.
14. Buglione M, Grisanti S, Almici C, Mangoni M, Polli C, et al. (2012) Circulating tumour cells in locally advanced head and neck cancer: preliminary report about their possible role in predicting response to non-surgical treatment and survival. Eur J Cancer 48: 3019-3026.
15. Bozec A, Ilie M, Dassonville O, Long E, Poissonnet G, et al. (2013) Significance of circulating tumor cell detection using the CellSearch system in patients with locally advanced head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 270: 2745-2749.
16. Alix-Panabieres C, Pantel K (2013) Circulating tumor cells: Liquid biopsy of cancer. Clin Chem 59: 110- 118.
17. Nel I, Baba HA, Ertle J, Weber F, Sitek B, et al. (2013) Individual profiling of circulating tumor cell composition and therapeutic outcome in patients with hepatocellular carcinoma. Transl Oncol 6: 420- 428.
18. Nel I, Gauler T, Hoffmann AC (2014) Circulating tumor cell composition and outcome in patients with solid tumors. Int J Clin Pharmacol Ther 52: 74-75.
19. Nel I, Gauler TC, Eberhardt WE, Nickel AC, Schuler M, et al. (2013) Formation and repair kinetics of Pt-(GpG) DNA adducts in extracted circulating tumour cells and response to platinum treatment. Br J Cancer.
20. Sobin LH, Compton CC (2010) TNM Seventh Edition: What's New, What's Changed Communication From the International Union Against Cancer and the American Joint Committee on Cancer. Cancer 116: 5336-5339.
21. Hoffmann AC, Wild P, Leicht C, Bertz S, Danenberg KD, et al. (2010) MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy. Neoplasia 12: 628-636.
22. Hoffmann AC, Danenberg KD, Taubert H, Danenberg PV, Wuerl P (2009) A three-gene signature for outcome in soft tissue sarcoma. Clin Cancer Res 15: 5191-5198.
23. Sarkar FH, Li Y, Wang Z, Kong D (2009) Pancreatic cancer stem cells and EMT in drug resistance and metastasis. Minerva Chir 64: 489-500.
24. Chong PP, Selvaratnam L, Abbas AA, Kamarul T (2012) Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells. J Orthop Res 30: 634-642.
25. Kassis I, Zangi L, Rivkin R, Levdansky L, Samuel S, et al. (2006) Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. Bone Marrow Transplant 37: 967-976.
26. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, et al. (2003) Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol 121: 368-374.
27. Roufosse CA, Direkze NC, Otto WR, Wright NA (2004) Circulating mesenchymal stem cells. Int J Biochem Cell Biol 36: 585-597.
28. Yang FC, Watanabe S, Tsuji K, Xu MJ, Kaneko A, et al. (1998) Human granulocyte colony-stimulating factor (G-CSF) stimulates the in vitro and in vivo development but not commitment of primitive multipotential progenitors from transgenic mice expressing the human G-CSF receptor. Blood 92: 4632- 4640.
29. Cesselli D, Beltrami AP, Rigo S, Bergamin N, D'Aurizio F, et al. (2009) Multipotent progenitor cells are present in human peripheral blood. Circ Res 104: 1225-1234.
30. Klopp AH, Spaeth EL, Dembinski JL, Woodward WA, Munshi A, et al. (2007) Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. Cancer Res 67: 11687-11695.
31. Yu M, Stott S, Toner M, Maheswaran S, Haber DA (2011) Circulating tumor cells: Approaches to isolation and characterization. J Cell Biol 192: 373-382.